EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
FRA:EWL • US28176E1082
73.36 EUR
+2.42 (+3.41%)
Last: Feb 27, 2026, 07:00 PM
EWL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EWL is quite expensive at the moment. It does show a decent growth rate. With these ratings, EWL could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
- EWL had positive earnings in the past year.
- EWL had a positive operating cash flow in the past year.
- EWL had positive earnings in each of the past 5 years.
- Of the past 5 years EWL 4 years had a positive operating cash flow.
1.2 Ratios
- EWL has a better Return On Assets (10.31%) than 90.77% of its industry peers.
- With a decent Return On Equity value of 13.40%, EWL is doing good in the industry, outperforming 78.46% of the companies in the same industry.
- The Return On Invested Capital of EWL (12.09%) is better than 87.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 12.09% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of EWL (23.25%) is better than 93.85% of its industry peers.
- In the last couple of years the Profit Margin of EWL has remained more or less at the same level.
- Looking at the Operating Margin, with a value of 27.73%, EWL belongs to the top of the industry, outperforming 96.92% of the companies in the same industry.
- In the last couple of years the Operating Margin of EWL has declined.
- The Gross Margin of EWL (78.19%) is better than 92.31% of its industry peers.
- In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
- There is no outstanding debt for EWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 12.29 indicates that EWL is not in any danger for bankruptcy at the moment.
- EWL has a better Altman-Z score (12.29) than 93.85% of its industry peers.
- The Debt to FCF ratio of EWL is 0.75, which is an excellent value as it means it would take EWL, only 0.75 years of fcf income to pay off all of its debts.
- EWL has a Debt to FCF ratio of 0.75. This is amongst the best in the industry. EWL outperforms 90.77% of its industry peers.
- EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
- EWL has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. EWL outperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.29 |
ROIC/WACC1.23
WACC9.86%
2.3 Liquidity
- EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of EWL (4.00) is better than 92.31% of its industry peers.
- A Quick Ratio of 3.29 indicates that EWL has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.29, EWL belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
- EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.29%.
- EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.67% yearly.
- The Revenue has grown by 10.86% in the past year. This is quite good.
- Measured over the past years, EWL shows a small growth in Revenue. The Revenue has been growing by 6.70% on average per year.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
3.2 Future
- The Earnings Per Share is expected to grow by 12.79% on average over the next years. This is quite good.
- The Revenue is expected to grow by 9.72% on average over the next years. This is quite good.
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- EWL is valuated quite expensively with a Price/Earnings ratio of 33.81.
- EWL's Price/Earnings ratio is in line with the industry average.
- When comparing the Price/Earnings ratio of EWL to the average of the S&P500 Index (27.10), we can say EWL is valued slightly more expensively.
- With a Price/Forward Earnings ratio of 29.15, EWL can be considered very expensive at the moment.
- Based on the Price/Forward Earnings ratio, EWL is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
- EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.81 | ||
| Fwd PE | 29.15 |
4.2 Price Multiples
- EWL's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EWL is more expensive than 66.15% of the companies in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 62.9 | ||
| EV/EBITDA | 24.74 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of EWL may justify a higher PE ratio.
- EWL's earnings are expected to grow with 13.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.1
PEG (5Y)5.07
EPS Next 2Y13.34%
EPS Next 3Y13.01%
5. Dividend
5.1 Amount
- EWL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:EWL (2/27/2026, 7:00:00 PM)
73.36
+2.42 (+3.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/amc
Earnings (Next)04-21 2026-04-21/amc
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap42.57B
Revenue(TTM)6.07B
Net Income(TTM)1.37B
Analysts79.53
Price Target81.61 (11.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)-2.06%
PT rev (3m)1.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.06%
EPS NY rev (1m)0.43%
EPS NY rev (3m)1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.81 | ||
| Fwd PE | 29.15 | ||
| P/S | 8.55 | ||
| P/FCF | 62.9 | ||
| P/OCF | 49.46 | ||
| P/B | 4.93 | ||
| P/tB | 6.88 | ||
| EV/EBITDA | 24.74 |
EPS(TTM)2.17
EY2.96%
EPS(NY)2.52
Fwd EY3.43%
FCF(TTM)1.17
FCFY1.59%
OCF(TTM)1.48
OCFY2.02%
SpS8.58
BVpS14.89
TBVpS10.66
PEG (NY)2.1
PEG (5Y)5.07
Graham Number26.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 12.09% | ||
| ROICexc | 18.01% | ||
| ROICexgc | 28.58% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.29 |
F-Score5
WACC9.86%
ROIC/WACC1.23
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
EBIT growth 1Y4.68%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year24.3%
EBIT Next 3Y14.62%
EBIT Next 5Y14.72%
FCF growth 1Y67.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.09%
OCF growth 3YN/A
OCF growth 5YN/A
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 6 / 10 to EWL.DE.
What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 7 / 10.
What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 33.81 and the Price/Book (PB) ratio is 4.93.